Iterum Therapeutics plc

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, NONOF has a market cap of 176.5B. Regarding current trading prices, ITRMF is priced at $0.02, while NONOF trades at $38.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas NONOF's P/E ratio is 11.07. In terms of profitability, ITRMF's ROE is +6.02%, compared to NONOF's ROE of +0.61%. Regarding short-term risk, ITRMF is more volatile compared to NONOF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check NONOF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, CSLLY has a market cap of 96B. Regarding current trading prices, ITRMF is priced at $0.02, while CSLLY trades at $24.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas CSLLY's P/E ratio is 16.10. In terms of profitability, ITRMF's ROE is +6.02%, compared to CSLLY's ROE of +0.08%. Regarding short-term risk, ITRMF is more volatile compared to CSLLY. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check CSLLY's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, UCBJF has a market cap of 61.4B. Regarding current trading prices, ITRMF is priced at $0.02, while UCBJF trades at $305.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas UCBJF's P/E ratio is 34.29. In terms of profitability, ITRMF's ROE is +6.02%, compared to UCBJF's ROE of +0.15%. Regarding short-term risk, ITRMF is more volatile compared to UCBJF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check UCBJF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, UCBJY has a market cap of 58.6B. Regarding current trading prices, ITRMF is priced at $0.02, while UCBJY trades at $154.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas UCBJY's P/E ratio is 32.76. In terms of profitability, ITRMF's ROE is +6.02%, compared to UCBJY's ROE of +0.15%. Regarding short-term risk, ITRMF is more volatile compared to UCBJY. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check UCBJY's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, ARGNF has a market cap of 55.4B. Regarding current trading prices, ITRMF is priced at $0.02, while ARGNF trades at $894.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas ARGNF's P/E ratio is 45.70. In terms of profitability, ITRMF's ROE is +6.02%, compared to ARGNF's ROE of +0.34%. Regarding short-term risk, ITRMF is more volatile compared to ARGNF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check ARGNF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, CMXHF has a market cap of 47.3B. Regarding current trading prices, ITRMF is priced at $0.02, while CMXHF trades at $97.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas CMXHF's P/E ratio is 15.79. In terms of profitability, ITRMF's ROE is +6.02%, compared to CMXHF's ROE of +0.08%. Regarding short-term risk, ITRMF is more volatile compared to CMXHF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check CMXHF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, WXXWY has a market cap of 19.3B. Regarding current trading prices, ITRMF is priced at $0.02, while WXXWY trades at $9.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas WXXWY's P/E ratio is 27.42. In terms of profitability, ITRMF's ROE is +6.02%, compared to WXXWY's ROE of +0.11%. Regarding short-term risk, ITRMF is more volatile compared to WXXWY. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check WXXWY's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, IVBXF has a market cap of 19.1B. Regarding current trading prices, ITRMF is priced at $0.02, while IVBXF trades at $11.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas IVBXF's P/E ratio is 158.73. In terms of profitability, ITRMF's ROE is +6.02%, compared to IVBXF's ROE of +0.05%. Regarding short-term risk, ITRMF is more volatile compared to IVBXF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check IVBXF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, WXIBF has a market cap of 19B. Regarding current trading prices, ITRMF is priced at $0.02, while WXIBF trades at $4.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas WXIBF's P/E ratio is 27.06. In terms of profitability, ITRMF's ROE is +6.02%, compared to WXIBF's ROE of +0.11%. Regarding short-term risk, ITRMF is more volatile compared to WXIBF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check WXIBF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, GNMSF has a market cap of 17.4B. Regarding current trading prices, ITRMF is priced at $0.02, while GNMSF trades at $281.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas GNMSF's P/E ratio is 18.34. In terms of profitability, ITRMF's ROE is +6.02%, compared to GNMSF's ROE of +0.19%. Regarding short-term risk, ITRMF is more volatile compared to GNMSF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check GNMSF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, SBHMY has a market cap of 14.2B. Regarding current trading prices, ITRMF is priced at $0.02, while SBHMY trades at $15.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas SBHMY's P/E ratio is 41.82. In terms of profitability, ITRMF's ROE is +6.02%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, ITRMF is more volatile compared to SBHMY. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check SBHMY's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, SBMFF has a market cap of 13.6B. Regarding current trading prices, ITRMF is priced at $0.02, while SBMFF trades at $0.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas SBMFF's P/E ratio is 25.33. In terms of profitability, ITRMF's ROE is +6.02%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, ITRMF is more volatile compared to SBMFF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check SBMFF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, BRRGF has a market cap of 9.5B. Regarding current trading prices, ITRMF is priced at $0.02, while BRRGF trades at $97.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas BRRGF's P/E ratio is -0.48. In terms of profitability, ITRMF's ROE is +6.02%, compared to BRRGF's ROE of -0.97%. Regarding short-term risk, ITRMF is less volatile compared to BRRGF. This indicates potentially lower risk in terms of short-term price fluctuations for ITRMF.Check BRRGF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, AAVXF has a market cap of 9.2B. Regarding current trading prices, ITRMF is priced at $0.02, while AAVXF trades at $115.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas AAVXF's P/E ratio is -22.11. In terms of profitability, ITRMF's ROE is +6.02%, compared to AAVXF's ROE of -1.65%. Regarding short-term risk, ITRMF is more volatile compared to AAVXF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check AAVXF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, ODTC has a market cap of 8B. Regarding current trading prices, ITRMF is priced at $0.02, while ODTC trades at $22,005.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas ODTC's P/E ratio is 1.07. In terms of profitability, ITRMF's ROE is +6.02%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, ITRMF is more volatile compared to ODTC. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check ODTC's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, TRSBF has a market cap of 7.1B. Regarding current trading prices, ITRMF is priced at $0.02, while TRSBF trades at $3.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas TRSBF's P/E ratio is 21.43. In terms of profitability, ITRMF's ROE is +6.02%, compared to TRSBF's ROE of +0.38%. Regarding short-term risk, ITRMF is more volatile compared to TRSBF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check TRSBF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, AKBLF has a market cap of 6.3B. Regarding current trading prices, ITRMF is priced at $0.02, while AKBLF trades at $31.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas AKBLF's P/E ratio is 37.32. In terms of profitability, ITRMF's ROE is +6.02%, compared to AKBLF's ROE of +0.20%. Regarding short-term risk, ITRMF is more volatile compared to AKBLF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check AKBLF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, REGMF has a market cap of 6.2B. Regarding current trading prices, ITRMF is priced at $0.02, while REGMF trades at $10.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas REGMF's P/E ratio is 57.63. In terms of profitability, ITRMF's ROE is +6.02%, compared to REGMF's ROE of +0.27%. Regarding short-term risk, ITRMF is more volatile compared to REGMF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check REGMF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, ITRMF is priced at $0.02, while ABCZF trades at $22.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, ITRMF's ROE is +6.02%, compared to ABCZF's ROE of +0.29%. Regarding short-term risk, ITRMF is more volatile compared to ABCZF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check ABCZF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, ITRMF is priced at $0.02, while LABFF trades at $90.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas LABFF's P/E ratio is 28.95. In terms of profitability, ITRMF's ROE is +6.02%, compared to LABFF's ROE of +0.23%. Regarding short-term risk, ITRMF is more volatile compared to LABFF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check LABFF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, SHJBF has a market cap of 4.3B. Regarding current trading prices, ITRMF is priced at $0.02, while SHJBF trades at $3.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas SHJBF's P/E ratio is -25.00. In terms of profitability, ITRMF's ROE is +6.02%, compared to SHJBF's ROE of -0.14%. Regarding short-term risk, ITRMF is more volatile compared to SHJBF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check SHJBF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, ZLDPF has a market cap of 3.6B. Regarding current trading prices, ITRMF is priced at $0.02, while ZLDPF trades at $51.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas ZLDPF's P/E ratio is 3.64. In terms of profitability, ITRMF's ROE is +6.02%, compared to ZLDPF's ROE of +0.48%. Regarding short-term risk, ITRMF is more volatile compared to ZLDPF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check ZLDPF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, TLPPF has a market cap of 3.6B. Regarding current trading prices, ITRMF is priced at $0.02, while TLPPF trades at $10.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas TLPPF's P/E ratio is -525.00. In terms of profitability, ITRMF's ROE is +6.02%, compared to TLPPF's ROE of -0.02%. Regarding short-term risk, ITRMF is more volatile compared to TLPPF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check TLPPF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, CAMRF has a market cap of 3.3B. Regarding current trading prices, ITRMF is priced at $0.02, while CAMRF trades at $55.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas CAMRF's P/E ratio is 41.04. In terms of profitability, ITRMF's ROE is +6.02%, compared to CAMRF's ROE of +0.19%. Regarding short-term risk, ITRMF is more volatile compared to CAMRF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check CAMRF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, ASPHF has a market cap of 3.2B. Regarding current trading prices, ITRMF is priced at $0.02, while ASPHF trades at $8.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas ASPHF's P/E ratio is -16.00. In terms of profitability, ITRMF's ROE is +6.02%, compared to ASPHF's ROE of -0.73%. Regarding short-term risk, ITRMF is more volatile compared to ASPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check ASPHF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, GNNSF has a market cap of 3.1B. Regarding current trading prices, ITRMF is priced at $0.02, while GNNSF trades at $1.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas GNNSF's P/E ratio is -5.68. In terms of profitability, ITRMF's ROE is +6.02%, compared to GNNSF's ROE of -0.13%. Regarding short-term risk, ITRMF is more volatile compared to GNNSF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check GNNSF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, BRCTF has a market cap of 2.9B. Regarding current trading prices, ITRMF is priced at $0.02, while BRCTF trades at $33.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas BRCTF's P/E ratio is 26.85. In terms of profitability, ITRMF's ROE is +6.02%, compared to BRCTF's ROE of +0.52%. Regarding short-term risk, ITRMF is more volatile compared to BRCTF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check BRCTF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, ITRMF is priced at $0.02, while MPSYF trades at $73.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, ITRMF's ROE is +6.02%, compared to MPSYF's ROE of -1.84%. Regarding short-term risk, ITRMF is more volatile compared to MPSYF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check MPSYF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, VGLS has a market cap of 2.6B. Regarding current trading prices, ITRMF is priced at $0.02, while VGLS trades at $0.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas VGLS's P/E ratio is N/A. In terms of profitability, ITRMF's ROE is +6.02%, compared to VGLS's ROE of +0.00%. Regarding short-term risk, ITRMF is less volatile compared to VGLS. This indicates potentially lower risk in terms of short-term price fluctuations for ITRMF.Check VGLS's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, BVNRY has a market cap of 2.5B. Regarding current trading prices, ITRMF is priced at $0.02, while BVNRY trades at $10.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas BVNRY's P/E ratio is 11.36. In terms of profitability, ITRMF's ROE is +6.02%, compared to BVNRY's ROE of +0.11%. Regarding short-term risk, ITRMF is more volatile compared to BVNRY. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check BVNRY's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, BVNKF has a market cap of 2.4B. Regarding current trading prices, ITRMF is priced at $0.02, while BVNKF trades at $30.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas BVNKF's P/E ratio is 11.17. In terms of profitability, ITRMF's ROE is +6.02%, compared to BVNKF's ROE of +0.11%. Regarding short-term risk, ITRMF is more volatile compared to BVNKF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check BVNKF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, INCPF has a market cap of 2.3B. Regarding current trading prices, ITRMF is priced at $0.02, while INCPF trades at $1.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas INCPF's P/E ratio is 25.83. In terms of profitability, ITRMF's ROE is +6.02%, compared to INCPF's ROE of +0.09%. Regarding short-term risk, ITRMF is more volatile compared to INCPF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check INCPF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, ASCLF has a market cap of 2.2B. Regarding current trading prices, ITRMF is priced at $0.02, while ASCLF trades at $2.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas ASCLF's P/E ratio is -42.00. In terms of profitability, ITRMF's ROE is +6.02%, compared to ASCLF's ROE of -0.19%. Regarding short-term risk, ITRMF is more volatile compared to ASCLF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check ASCLF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, GENSF has a market cap of 2.2B. Regarding current trading prices, ITRMF is priced at $0.02, while GENSF trades at $33.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas GENSF's P/E ratio is 34.90. In terms of profitability, ITRMF's ROE is +6.02%, compared to GENSF's ROE of +0.10%. Regarding short-term risk, ITRMF is more volatile compared to GENSF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check GENSF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, GLPGF has a market cap of 2.2B. Regarding current trading prices, ITRMF is priced at $0.02, while GLPGF trades at $33.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas GLPGF's P/E ratio is -4.15. In terms of profitability, ITRMF's ROE is +6.02%, compared to GLPGF's ROE of +0.11%. Regarding short-term risk, ITRMF is more volatile compared to GLPGF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check GLPGF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, MEOBF has a market cap of 2.1B. Regarding current trading prices, ITRMF is priced at $0.02, while MEOBF trades at $1.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas MEOBF's P/E ratio is -22.86. In terms of profitability, ITRMF's ROE is +6.02%, compared to MEOBF's ROE of -0.14%. Regarding short-term risk, ITRMF is more volatile compared to MEOBF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check MEOBF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, PHMMF has a market cap of 1.8B. Regarding current trading prices, ITRMF is priced at $0.02, while PHMMF trades at $106.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas PHMMF's P/E ratio is 46.29. In terms of profitability, ITRMF's ROE is +6.02%, compared to PHMMF's ROE of +0.35%. Regarding short-term risk, ITRMF is more volatile compared to PHMMF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check PHMMF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, ONTTF has a market cap of 1.6B. Regarding current trading prices, ITRMF is priced at $0.02, while ONTTF trades at $1.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas ONTTF's P/E ratio is -8.30. In terms of profitability, ITRMF's ROE is +6.02%, compared to ONTTF's ROE of -0.29%. Regarding short-term risk, ITRMF is more volatile compared to ONTTF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check ONTTF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, ITRMF is priced at $0.02, while BIESF trades at $32.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas BIESF's P/E ratio is -44.44. In terms of profitability, ITRMF's ROE is +6.02%, compared to BIESF's ROE of -0.05%. Regarding short-term risk, ITRMF is more volatile compared to BIESF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check BIESF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, CSPHF has a market cap of 1.5B. Regarding current trading prices, ITRMF is priced at $0.02, while CSPHF trades at $1.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas CSPHF's P/E ratio is -20.20. In terms of profitability, ITRMF's ROE is +6.02%, compared to CSPHF's ROE of -0.64%. Regarding short-term risk, ITRMF is more volatile compared to CSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check CSPHF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, HBMHF has a market cap of 1.3B. Regarding current trading prices, ITRMF is priced at $0.02, while HBMHF trades at $1.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas HBMHF's P/E ratio is 17.33. In terms of profitability, ITRMF's ROE is +6.02%, compared to HBMHF's ROE of +0.36%. Regarding short-term risk, ITRMF is more volatile compared to HBMHF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check HBMHF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, SNBIF has a market cap of 1.3B. Regarding current trading prices, ITRMF is priced at $0.02, while SNBIF trades at $16.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas SNBIF's P/E ratio is -49.85. In terms of profitability, ITRMF's ROE is +6.02%, compared to SNBIF's ROE of -0.89%. Regarding short-term risk, ITRMF is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for ITRMF.Check SNBIF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, PHGUF has a market cap of 1.2B. Regarding current trading prices, ITRMF is priced at $0.02, while PHGUF trades at $1.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas PHGUF's P/E ratio is -175.00. In terms of profitability, ITRMF's ROE is +6.02%, compared to PHGUF's ROE of +0.01%. Regarding short-term risk, ITRMF is more volatile compared to PHGUF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check PHGUF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, MDCLF has a market cap of 1.2B. Regarding current trading prices, ITRMF is priced at $0.02, while MDCLF trades at $34.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas MDCLF's P/E ratio is -47.76. In terms of profitability, ITRMF's ROE is +6.02%, compared to MDCLF's ROE of +0.84%. Regarding short-term risk, ITRMF is more volatile compared to MDCLF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check MDCLF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, NURPF has a market cap of 1.1B. Regarding current trading prices, ITRMF is priced at $0.02, while NURPF trades at $8.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas NURPF's P/E ratio is 55.16. In terms of profitability, ITRMF's ROE is +6.02%, compared to NURPF's ROE of +0.09%. Regarding short-term risk, ITRMF is more volatile compared to NURPF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check NURPF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, CSBTF has a market cap of 1.1B. Regarding current trading prices, ITRMF is priced at $0.02, while CSBTF trades at $27.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas CSBTF's P/E ratio is 347.38. In terms of profitability, ITRMF's ROE is +6.02%, compared to CSBTF's ROE of +0.02%. Regarding short-term risk, ITRMF is more volatile compared to CSBTF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check CSBTF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, IDRSF has a market cap of 1.1B. Regarding current trading prices, ITRMF is priced at $0.02, while IDRSF trades at $4.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas IDRSF's P/E ratio is -6.55. In terms of profitability, ITRMF's ROE is +6.02%, compared to IDRSF's ROE of +0.10%. Regarding short-term risk, ITRMF is more volatile compared to IDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check IDRSF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, PPTDF has a market cap of 1B. Regarding current trading prices, ITRMF is priced at $0.02, while PPTDF trades at $7.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas PPTDF's P/E ratio is -44.39. In terms of profitability, ITRMF's ROE is +6.02%, compared to PPTDF's ROE of -0.03%. Regarding short-term risk, ITRMF is more volatile compared to PPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check PPTDF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, BTTAY has a market cap of 943M. Regarding current trading prices, ITRMF is priced at $0.02, while BTTAY trades at $24.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, ITRMF's ROE is +6.02%, compared to BTTAY's ROE of -0.05%. Regarding short-term risk, ITRMF is more volatile compared to BTTAY. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check BTTAY's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, TKBIF has a market cap of 879M. Regarding current trading prices, ITRMF is priced at $0.02, while TKBIF trades at $7.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas TKBIF's P/E ratio is -22.12. In terms of profitability, ITRMF's ROE is +6.02%, compared to TKBIF's ROE of N/A. Regarding short-term risk, ITRMF is less volatile compared to TKBIF. This indicates potentially lower risk in terms of short-term price fluctuations for ITRMF.Check TKBIF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, BPMUF has a market cap of 853.7M. Regarding current trading prices, ITRMF is priced at $0.02, while BPMUF trades at $69.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas BPMUF's P/E ratio is 9.77. In terms of profitability, ITRMF's ROE is +6.02%, compared to BPMUF's ROE of +0.35%. Regarding short-term risk, ITRMF is more volatile compared to BPMUF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check BPMUF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, IVEVF has a market cap of 799.6M. Regarding current trading prices, ITRMF is priced at $0.02, while IVEVF trades at $5.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas IVEVF's P/E ratio is -2.58. In terms of profitability, ITRMF's ROE is +6.02%, compared to IVEVF's ROE of +18.92%. Regarding short-term risk, ITRMF is more volatile compared to IVEVF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check IVEVF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, VBIZF has a market cap of 724.5M. Regarding current trading prices, ITRMF is priced at $0.02, while VBIZF trades at $0.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas VBIZF's P/E ratio is 34.34. In terms of profitability, ITRMF's ROE is +6.02%, compared to VBIZF's ROE of +0.06%. Regarding short-term risk, ITRMF is more volatile compared to VBIZF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check VBIZF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, CKDXF has a market cap of 601.9M. Regarding current trading prices, ITRMF is priced at $0.02, while CKDXF trades at $0.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, ITRMF's ROE is +6.02%, compared to CKDXF's ROE of +0.84%. Regarding short-term risk, ITRMF is more volatile compared to CKDXF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check CKDXF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, SOLTF has a market cap of 579.2M. Regarding current trading prices, ITRMF is priced at $0.02, while SOLTF trades at $6.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas SOLTF's P/E ratio is -7.36. In terms of profitability, ITRMF's ROE is +6.02%, compared to SOLTF's ROE of -0.19%. Regarding short-term risk, ITRMF is more volatile compared to SOLTF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check SOLTF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, GNFTF has a market cap of 553.4M. Regarding current trading prices, ITRMF is priced at $0.02, while GNFTF trades at $11.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas GNFTF's P/E ratio is -5.47. In terms of profitability, ITRMF's ROE is +6.02%, compared to GNFTF's ROE of -5.96%. Regarding short-term risk, ITRMF is more volatile compared to GNFTF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check GNFTF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, CYDY has a market cap of 507.5M. Regarding current trading prices, ITRMF is priced at $0.02, while CYDY trades at $0.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas CYDY's P/E ratio is -9.29. In terms of profitability, ITRMF's ROE is +6.02%, compared to CYDY's ROE of +0.37%. Regarding short-term risk, ITRMF is more volatile compared to CYDY. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check CYDY's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, INRLF has a market cap of 504.2M. Regarding current trading prices, ITRMF is priced at $0.02, while INRLF trades at $2.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas INRLF's P/E ratio is -3.71. In terms of profitability, ITRMF's ROE is +6.02%, compared to INRLF's ROE of -0.75%. Regarding short-term risk, ITRMF is more volatile compared to INRLF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check INRLF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, ITRMF is priced at $0.02, while RAONF trades at $2.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas RAONF's P/E ratio is -43.33. In terms of profitability, ITRMF's ROE is +6.02%, compared to RAONF's ROE of -0.26%. Regarding short-term risk, ITRMF is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for ITRMF.Check RAONF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, GNFTY has a market cap of 447.8M. Regarding current trading prices, ITRMF is priced at $0.02, while GNFTY trades at $8.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas GNFTY's P/E ratio is -9.94. In terms of profitability, ITRMF's ROE is +6.02%, compared to GNFTY's ROE of -0.69%. Regarding short-term risk, ITRMF is more volatile compared to GNFTY. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check GNFTY's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, ITRMF is priced at $0.02, while TBGNF trades at $0.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, ITRMF's ROE is +6.02%, compared to TBGNF's ROE of -0.01%. Regarding short-term risk, ITRMF is more volatile compared to TBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check TBGNF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, PTCHF has a market cap of 428.4M. Regarding current trading prices, ITRMF is priced at $0.02, while PTCHF trades at $1.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas PTCHF's P/E ratio is 10.35. In terms of profitability, ITRMF's ROE is +6.02%, compared to PTCHF's ROE of +0.13%. Regarding short-term risk, ITRMF is more volatile compared to PTCHF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check PTCHF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, NWPHF has a market cap of 399.3M. Regarding current trading prices, ITRMF is priced at $0.02, while NWPHF trades at $20.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas NWPHF's P/E ratio is N/A. In terms of profitability, ITRMF's ROE is +6.02%, compared to NWPHF's ROE of +16.69%. Regarding short-term risk, ITRMF is more volatile compared to NWPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check NWPHF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, AVCTF has a market cap of 390.7M. Regarding current trading prices, ITRMF is priced at $0.02, while AVCTF trades at $0.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas AVCTF's P/E ratio is -5.95. In terms of profitability, ITRMF's ROE is +6.02%, compared to AVCTF's ROE of -3.76%. Regarding short-term risk, ITRMF is more volatile compared to AVCTF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check AVCTF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, CLVLY has a market cap of 351.4M. Regarding current trading prices, ITRMF is priced at $0.02, while CLVLY trades at $7.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas CLVLY's P/E ratio is 15.56. In terms of profitability, ITRMF's ROE is +6.02%, compared to CLVLY's ROE of +0.13%. Regarding short-term risk, ITRMF is more volatile compared to CLVLY. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check CLVLY's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, SLNCF has a market cap of 340.1M. Regarding current trading prices, ITRMF is priced at $0.02, while SLNCF trades at $2.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas SLNCF's P/E ratio is -3.81. In terms of profitability, ITRMF's ROE is +6.02%, compared to SLNCF's ROE of -3.59%. Regarding short-term risk, ITRMF is more volatile compared to SLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check SLNCF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, CLVLF has a market cap of 315.2M. Regarding current trading prices, ITRMF is priced at $0.02, while CLVLF trades at $6.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas CLVLF's P/E ratio is 12.56. In terms of profitability, ITRMF's ROE is +6.02%, compared to CLVLF's ROE of +0.13%. Regarding short-term risk, ITRMF is more volatile compared to CLVLF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check CLVLF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, NGENF has a market cap of 312.9M. Regarding current trading prices, ITRMF is priced at $0.02, while NGENF trades at $3.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas NGENF's P/E ratio is -15.19. In terms of profitability, ITRMF's ROE is +6.02%, compared to NGENF's ROE of -974.60%. Regarding short-term risk, ITRMF is more volatile compared to NGENF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check NGENF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, SPHDF has a market cap of 312.8M. Regarding current trading prices, ITRMF is priced at $0.02, while SPHDF trades at $22.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas SPHDF's P/E ratio is -3.23. In terms of profitability, ITRMF's ROE is +6.02%, compared to SPHDF's ROE of -5.22%. Regarding short-term risk, ITRMF is more volatile compared to SPHDF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check SPHDF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, FGHQF has a market cap of 304.2M. Regarding current trading prices, ITRMF is priced at $0.02, while FGHQF trades at $0.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas FGHQF's P/E ratio is 15.00. In terms of profitability, ITRMF's ROE is +6.02%, compared to FGHQF's ROE of +0.02%. Regarding short-term risk, ITRMF is more volatile compared to FGHQF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check FGHQF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, NWBO has a market cap of 302.4M. Regarding current trading prices, ITRMF is priced at $0.02, while NWBO trades at $0.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas NWBO's P/E ratio is -3.27. In terms of profitability, ITRMF's ROE is +6.02%, compared to NWBO's ROE of +0.72%. Regarding short-term risk, ITRMF is more volatile compared to NWBO. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check NWBO's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, ITRMF is priced at $0.02, while PBBIF trades at $24.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, ITRMF's ROE is +6.02%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, ITRMF is more volatile compared to PBBIF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check PBBIF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, ORPOF has a market cap of 260.3M. Regarding current trading prices, ITRMF is priced at $0.02, while ORPOF trades at $11.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas ORPOF's P/E ratio is -11.86. In terms of profitability, ITRMF's ROE is +6.02%, compared to ORPOF's ROE of N/A. Regarding short-term risk, ITRMF is more volatile compared to ORPOF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check ORPOF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, ORYZF has a market cap of 258.9M. Regarding current trading prices, ITRMF is priced at $0.02, while ORYZF trades at $3.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas ORYZF's P/E ratio is -83.50. In terms of profitability, ITRMF's ROE is +6.02%, compared to ORYZF's ROE of -0.03%. Regarding short-term risk, ITRMF is more volatile compared to ORYZF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check ORYZF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, HLOSF has a market cap of 247.6M. Regarding current trading prices, ITRMF is priced at $0.02, while HLOSF trades at $2.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas HLOSF's P/E ratio is -13.53. In terms of profitability, ITRMF's ROE is +6.02%, compared to HLOSF's ROE of -0.80%. Regarding short-term risk, ITRMF is more volatile compared to HLOSF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check HLOSF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, HNSBF has a market cap of 245.8M. Regarding current trading prices, ITRMF is priced at $0.02, while HNSBF trades at $2.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas HNSBF's P/E ratio is -4.08. In terms of profitability, ITRMF's ROE is +6.02%, compared to HNSBF's ROE of +1.23%. Regarding short-term risk, ITRMF is more volatile compared to HNSBF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check HNSBF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, SPHRY has a market cap of 226.5M. Regarding current trading prices, ITRMF is priced at $0.02, while SPHRY trades at $5.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas SPHRY's P/E ratio is -89.67. In terms of profitability, ITRMF's ROE is +6.02%, compared to SPHRY's ROE of -0.05%. Regarding short-term risk, ITRMF is more volatile compared to SPHRY. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check SPHRY's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, CMVLF has a market cap of 222.8M. Regarding current trading prices, ITRMF is priced at $0.02, while CMVLF trades at $3.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas CMVLF's P/E ratio is -4.60. In terms of profitability, ITRMF's ROE is +6.02%, compared to CMVLF's ROE of -0.70%. Regarding short-term risk, ITRMF is more volatile compared to CMVLF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check CMVLF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, CAIHF has a market cap of 217.4M. Regarding current trading prices, ITRMF is priced at $0.02, while CAIHF trades at $0.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas CAIHF's P/E ratio is 2.80. In terms of profitability, ITRMF's ROE is +6.02%, compared to CAIHF's ROE of +0.12%. Regarding short-term risk, ITRMF is less volatile compared to CAIHF. This indicates potentially lower risk in terms of short-term price fluctuations for ITRMF.Check CAIHF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, BOVNF has a market cap of 216.4M. Regarding current trading prices, ITRMF is priced at $0.02, while BOVNF trades at $3.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas BOVNF's P/E ratio is -7.00. In terms of profitability, ITRMF's ROE is +6.02%, compared to BOVNF's ROE of -0.47%. Regarding short-term risk, ITRMF is more volatile compared to BOVNF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check BOVNF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, ITRMF is priced at $0.02, while FPHAF trades at $3.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, ITRMF's ROE is +6.02%, compared to FPHAF's ROE of +0.00%. Regarding short-term risk, ITRMF is more volatile compared to FPHAF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check FPHAF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, ITRMF is priced at $0.02, while ADOCY trades at $11.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, ITRMF's ROE is +6.02%, compared to ADOCY's ROE of +1.86%. Regarding short-term risk, ITRMF is more volatile compared to ADOCY. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check ADOCY's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, SCNLF has a market cap of 147.4M. Regarding current trading prices, ITRMF is priced at $0.02, while SCNLF trades at $0.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas SCNLF's P/E ratio is -14.20. In terms of profitability, ITRMF's ROE is +6.02%, compared to SCNLF's ROE of +0.90%. Regarding short-term risk, ITRMF is more volatile compared to SCNLF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check SCNLF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, SPHRF has a market cap of 147.3M. Regarding current trading prices, ITRMF is priced at $0.02, while SPHRF trades at $0.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas SPHRF's P/E ratio is -35.00. In terms of profitability, ITRMF's ROE is +6.02%, compared to SPHRF's ROE of -0.16%. Regarding short-term risk, ITRMF is more volatile compared to SPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check SPHRF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, TRGNF has a market cap of 144.2M. Regarding current trading prices, ITRMF is priced at $0.02, while TRGNF trades at $1.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas TRGNF's P/E ratio is -3.03. In terms of profitability, ITRMF's ROE is +6.02%, compared to TRGNF's ROE of -0.64%. Regarding short-term risk, ITRMF is more volatile compared to TRGNF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check TRGNF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, AMGXF has a market cap of 142.5M. Regarding current trading prices, ITRMF is priced at $0.02, while AMGXF trades at $0.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, ITRMF's ROE is +6.02%, compared to AMGXF's ROE of -0.45%. Regarding short-term risk, ITRMF is more volatile compared to AMGXF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check AMGXF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, IPHYF has a market cap of 140.7M. Regarding current trading prices, ITRMF is priced at $0.02, while IPHYF trades at $1.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas IPHYF's P/E ratio is -2.31. In terms of profitability, ITRMF's ROE is +6.02%, compared to IPHYF's ROE of +5.94%. Regarding short-term risk, ITRMF is more volatile compared to IPHYF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check IPHYF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, KNTPF has a market cap of 140.7M. Regarding current trading prices, ITRMF is priced at $0.02, while KNTPF trades at $0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas KNTPF's P/E ratio is -5.00. In terms of profitability, ITRMF's ROE is +6.02%, compared to KNTPF's ROE of -0.63%. Regarding short-term risk, ITRMF is more volatile compared to KNTPF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check KNTPF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, BRIBF has a market cap of 135.7M. Regarding current trading prices, ITRMF is priced at $0.02, while BRIBF trades at $0.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas BRIBF's P/E ratio is -3.76. In terms of profitability, ITRMF's ROE is +6.02%, compared to BRIBF's ROE of -0.09%. Regarding short-term risk, ITRMF is more volatile compared to BRIBF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check BRIBF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, HBPCF has a market cap of 132.1M. Regarding current trading prices, ITRMF is priced at $0.02, while HBPCF trades at $1.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas HBPCF's P/E ratio is -43.25. In terms of profitability, ITRMF's ROE is +6.02%, compared to HBPCF's ROE of -0.37%. Regarding short-term risk, ITRMF is more volatile compared to HBPCF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check HBPCF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, ITRMF is priced at $0.02, while AAPGV trades at $17.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas AAPGV's P/E ratio is N/A. In terms of profitability, ITRMF's ROE is +6.02%, compared to AAPGV's ROE of -1.24%. Regarding short-term risk, ITRMF is more volatile compared to AAPGV. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check AAPGV's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, BXPHF has a market cap of 119.4M. Regarding current trading prices, ITRMF is priced at $0.02, while BXPHF trades at $0.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas BXPHF's P/E ratio is -2.00. In terms of profitability, ITRMF's ROE is +6.02%, compared to BXPHF's ROE of -1.31%. Regarding short-term risk, ITRMF is more volatile compared to BXPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check BXPHF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, ITRMF is priced at $0.02, while PSTTF trades at $0.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, ITRMF's ROE is +6.02%, compared to PSTTF's ROE of N/A. Regarding short-term risk, ITRMF is more volatile compared to PSTTF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check PSTTF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, JWCTF has a market cap of 116.6M. Regarding current trading prices, ITRMF is priced at $0.02, while JWCTF trades at $0.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas JWCTF's P/E ratio is -1.40. In terms of profitability, ITRMF's ROE is +6.02%, compared to JWCTF's ROE of -0.75%. Regarding short-term risk, ITRMF is more volatile compared to JWCTF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check JWCTF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, ATGGF has a market cap of 113.5M. Regarding current trading prices, ITRMF is priced at $0.02, while ATGGF trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas ATGGF's P/E ratio is N/A. In terms of profitability, ITRMF's ROE is +6.02%, compared to ATGGF's ROE of -1.34%. Regarding short-term risk, ITRMF is more volatile compared to ATGGF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check ATGGF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, NDTP has a market cap of 112M. Regarding current trading prices, ITRMF is priced at $0.02, while NDTP trades at $0.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas NDTP's P/E ratio is -2.41. In terms of profitability, ITRMF's ROE is +6.02%, compared to NDTP's ROE of -0.33%. Regarding short-term risk, ITRMF is more volatile compared to NDTP. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check NDTP's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, ITRMF is priced at $0.02, while EPRXF trades at $3.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, ITRMF's ROE is +6.02%, compared to EPRXF's ROE of -4.83%. Regarding short-term risk, ITRMF is more volatile compared to EPRXF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check EPRXF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, ITRMF is priced at $0.02, while ADOIF trades at $8.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, ITRMF's ROE is +6.02%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, ITRMF is more volatile compared to ADOIF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check ADOIF's competition here

ITRMF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ITRMF stands at 1.1M. In comparison, MSCLF has a market cap of 96.6M. Regarding current trading prices, ITRMF is priced at $0.02, while MSCLF trades at $6.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ITRMF currently has a P/E ratio of -0.03, whereas MSCLF's P/E ratio is 2.43. In terms of profitability, ITRMF's ROE is +6.02%, compared to MSCLF's ROE of -0.70%. Regarding short-term risk, ITRMF is more volatile compared to MSCLF. This indicates potentially higher risk in terms of short-term price fluctuations for ITRMF.Check MSCLF's competition here